Acasti Pharma redomiciles from Canada to Delaware effective October 7, 2024

Grace Therapeutics, Inc.

Changed jurisdiction from Quebec to British Columbia (Oct 1) and then to Delaware (Oct 7, 2024).
Shareholders approved continuance and domestication at Sept 30, 2024 meeting.
Rights of common stockholders now governed by Delaware General Corporation Law and new Charter/Bylaws.
Entered into indemnification agreements with each executive officer and director.
Common stock continues trading on Nasdaq under symbol ACST.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Grace Therapeutics, Inc.: Adoption of Certificate of Incorporation and Bylaws in Delaware following domestication (effective 2024-10-07).

Change: bylaw amendment
Effective: 2024-10-07

Exact text from the filing

The Charter and the Bylaws became effective as of October 7, 2024.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Grace Therapeutics, Inc.: Adoption of Notice of Articles and Articles of Acasti British Columbia following continuance (effective 2024-10-01).

Effective: 2024-10-01

Exact text from the filing

The Notice of Articles and the Articles became effective as of October 1, 2024.

View on SEC.gov

256 governance changes filed in the last 30 days. Browse all governance changes →

Grace Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-24-042968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.